Article Details
Retrieved on: 2024-08-19 20:27:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
HC Wainwright reaffirmed a "buy" rating and set a $113.00 price target on shares of BioNTech in a research note on Monday.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here